Citations (497)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Martha B Ramírez Rosas, Sieneke Labruijere, Carlos M Villalón & Antoinette Maassen VanDenBrink. (2013) Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opinion on Pharmacotherapy 14:12, pages 1599-1610.
Read now
Read now
Itzhak Z. Ben-Zion, Gal Meiri, Asher Shiber, Dan Buskila & Jonathan Benjamin. (2001) Serotonin Blockade Does Not Affect Nonarticular Tenderness in Healthy Volunteers. Journal of Musculoskeletal Pain 9:3, pages 43-49.
Read now
Read now
Pramod R Saxena & Michel D Ferrari. (1996) Monthly Update: Central & Peripheral Nervous Systems: Pharmacology of antimigraine 5-HT1D receptor agonists. Expert Opinion on Investigational Drugs 5:5, pages 581-593.
Read now
Read now
K. Chaouche-Teyara, B. Fournier, M. Safar & H. Dabirë. (1994) Systemic and Regional Haemodynamic Effects of 1–(2, 5–Dimethoxy-4–IODO-Phenyl)-2–Aminopropane (DOI) and α-Methyl-5–HT, in the Anaesthetised Rat. Clinical and Experimental Hypertension 16:6, pages 779-798.
Read now
Read now
Bryan L. Roth. (1994) Multiple Serotonin Receptors: Clinical and Experimental Aspects. Annals of Clinical Psychiatry 6:2, pages 67-78.
Read now
Read now
Lars Tanum. (1993) The effect of mianserin in chronic idiopathic abdominal pain A pilot study. Nordic Journal of Psychiatry 47:5, pages 351-354.
Read now
Read now
D. Hoyer & P. Schoeffter. (1991) 5-HT Receptors: Subtypes and Second Messengers. Journal of Receptor Research 11:1-4, pages 197-214.
Read now
Read now
Stuart A. Montgomery, T. Bullock & Roger M. Pinder. (1991) The clinical profile of mianserin. Nordisk Psykiatrisk Tidsskrift 45:sup24, pages 27-35.
Read now
Read now
Roger M. Pinder. (1991) Mianserin: Pharmacological and clinical correlates. Nordisk Psykiatrisk Tidsskrift 45:sup24, pages 13-26.
Read now
Read now
J. D. Stephenson. (1990) Neuropharmacological Studies of the Serotonergic System. International Review of Psychiatry 2:2, pages 157-178.
Read now
Read now
Articles from other publishers (487)
Liangsuo Ma, Kathryn A. Cunningham, Noelle C. Anastasio, James M. Bjork, Brian A. Taylor, Albert J. Arias, Brien P. Riley, Andrew D. Snyder & F. Gerard Moeller. (2022) A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine. Translational Psychiatry 12:1.
Crossref
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Crossref
Holli-Joi Sullivan, Amanda Tursi, Kelly Moore, Alexandra Campbell, Cecilia Floyd & Chun Wu. (2020)
Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT
1b
) Using Molecular Dynamics Simulations and Dynamic Network Analysis
. Journal of Chemical Information and Modeling 60:3, pages 1749-1765.
Crossref
Crossref
Abimael González-Hernández, Bruno A. Marichal-Cancino, Jair Lozano-Cuenca, Antoinette MaassenVanDenBrink & Carlos M. Villalón. (2019) Functional Characterization of the Prejunctional Receptors Mediating the Inhibition by Ergotamine of the Rat Perivascular Sensory Peptidergic Drive. ACS Chemical Neuroscience 10:7, pages 3173-3182.
Crossref
Crossref
Daniel Hoyer. 2019. The Serotonin System. The Serotonin System
63
93
.
O. J. Onaolapo, T. B. Paul & A. Y. Onaolapo. (2017) Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours. Metabolic Brain Disease 32:5, pages 1475-1489.
Crossref
Crossref
Sayyed Mohammad Hadi Alavi, Kazue Nagasawa, Keisuke G. Takahashi & Makoto Osada. 2017. Serotonin - A Chemical Messenger Between All Types of Living Cells. Serotonin - A Chemical Messenger Between All Types of Living Cells.
Amanda L. Persons, Stephanie E. Tedford & T. Celeste. (2017) Mirtazapine and ketanserin alter preference for gambling-like schedules of reinforcement in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 77, pages 178-184.
Crossref
Crossref
Zhenbo Huang, Nicolas Thiebaud & Debra Ann Fadool. (2017) Differential serotonergic modulation across the main and accessory olfactory bulbs. The Journal of Physiology 595:11, pages 3515-3533.
Crossref
Crossref
Daniel Hoyer. (2017) 5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice Rapport. ACS Chemical Neuroscience 8:5, pages 908-919.
Crossref
Crossref
Jose M. Palacios, Angel Pazos & Daniel Hoyer. (2017) A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment. Psychopharmacology 234:9-10, pages 1395-1418.
Crossref
Crossref
Guadalupe C. Vidal-Cantú, Mildred Jiménez-Hernández, Héctor I. Rocha-González, Carlos M. Villalón, Vinicio Granados-Soto & Enriqueta Muñoz-Islas. (2016) Role of 5-HT5A and 5-HT1B/1D receptors in the antinociception produced by ergotamine and valerenic acid in the rat formalin test. European Journal of Pharmacology 781, pages 109-116.
Crossref
Crossref
G. Bezzina, S. Body, T. H. C. Cheung, C. L. Hampson, C. M. Bradshaw, J. C. Glennon & E. Szabadi. (2014) Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. Psychopharmacology 232:4, pages 699-711.
Crossref
Crossref
Gergely Orban, Cristiano Bombardi, Antonella Marino Gammazza, Roberto Colangeli, Massimo Pierucci, Cristoforo Pomara, Mauro Pessia, Fabio Bucchieri, Benigno Arcangelo, Ilse Smolders, Philippe De Deurwaerdère & Giuseppe Di Giovanni. (2014) Role(s) of the 5-HT2C Receptor in the Development of Maximal Dentate Activation in the Hippocampus of Anesthetized Rats. CNS Neuroscience & Therapeutics 20:7, pages 651-661.
Crossref
Crossref
Sonia Torres-Sanchez, Cristina Alba-Delgado, Meritxell Llorca-Torralba, Juan A. Mico & Esther Berrocoso. (2013) Effect of tapentadol on neurons in the locus coeruleus. Neuropharmacology 72, pages 250-258.
Crossref
Crossref
Carl Dahlöf & Antoinette Maassen Van Den Brink. (2012) Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan – Basic Science in Relation to Migraine Treatment. Headache: The Journal of Head and Face Pain 52:4, pages 707-714.
Crossref
Crossref
P. Panther, S. Nullmeier, H. Dobrowolny, H. Schwegler & R. Wolf. (2012) CPB-K mice a mouse model of schizophrenia? Differences in dopaminergic, serotonergic and behavioral markers compared to BALB/cJ mice. Behavioural Brain Research 230:1, pages 215-228.
Crossref
Crossref
Adam L. Halberstadt & Mark A. Geyer. (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61:3, pages 364-381.
Crossref
Crossref
Russell E Poland & Alan Frazer. (1991) Corticosterone and prolactin response to TFMPP in rats during repeated antidepressant administration. Journal of Pharmacy and Pharmacology 43:1, pages 54-56.
Crossref
Crossref
H O Kalkman, V Neumann & V Brauner. (1989) Supersensitivity of atherosclerotic rabbit aorta to ergometrine is mediated by 5-HT2 receptors. Journal of Pharmacy and Pharmacology 41:12, pages 876-878.
Crossref
Crossref
Ray W Fuller, Kenneth W Perry & John S Ward. (1989) Decreased 5-hydroxytryptamine turnover in striatum and other brain regions after administration of 5-methoxy-3-(di-n-propylamino)-chroman to rats. Journal of Pharmacy and Pharmacology 41:11, pages 805-806.
Crossref
Crossref
López-Vázquez Miguel Ángel, Gutiérrez-Guzmán Blanca Érika, Cervantes Miguel & Olvera-Cortés María Esther. 2011. 5-HT2C Receptors in the Pathophysiology of CNS Disease. 5-HT2C Receptors in the Pathophysiology of CNS Disease
461
507
.
Matthew W. Hale, Philip L. Johnson, Alex M. Westerman, Jolane K. Abrams, Anantha Shekhar & Christopher A. Lowry. (2010) Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:7, pages 1285-1293.
Crossref
Crossref
Jair Lozano-Cuenca, Enriqueta Muñoz-Islas, Abimael González-Hernández, David Centurión, Luis E. Cobos-Puc, Araceli Sánchez-López, Heinz H. Pertz & Carlos M. Villalón. (2009) Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats. European Journal of Pharmacology 612:1-3, pages 80-86.
Crossref
Crossref
Qiao Jun Zhang, Xin Liu, Jian Liu, Shuang Wang, Umar Ali, Zhong Heng Wu & Tao Wang. (2009) Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats. Brain Research 1256, pages 180-189.
Crossref
Crossref
Luis E. Cobos-Puc, Carlos M. Villalón, Araceli Sánchez-López, Martha B. Ramírez-Rosas, Jair Lozano-Cuenca, Heinz H. Pertz, Tilo Görnemann & David Centurión. (2008) Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Naunyn-Schmiedeberg's Archives of Pharmacology 379:2, pages 137-148.
Crossref
Crossref
N. Gaur, S. Gautam, M. Gaur, P. Sharma, G. Dadheech & S. Mishra. (2008) The biochemical womb of schizophrenia: A review. Indian Journal of Clinical Biochemistry 23:4, pages 307-327.
Crossref
Crossref
Aart S. de Leeuw & Herman G.M. Westenberg. (2008) Hypersensitivity of 5-HT2 receptors in OCD patients. Journal of Psychiatric Research 42:11, pages 894-901.
Crossref
Crossref
Alice C. Johnstone, Rod A. Lea, Katie A. Brennan, Susan Schenk, Martin A. Kennedy & Paul S. Fitzmaurice. (2016) Review: Benzylpiperazine: a drug of abuse?. Journal of Psychopharmacology 21:8, pages 888-894.
Crossref
Crossref
K. Stachowicz, K. Gołembiowska, M. Sowa, G. Nowak, E. Chojnacka-Wójcik & A. Pilc. (2007) Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Neuropharmacology 53:6, pages 741-748.
Crossref
Crossref
Ellen A. Walker, Edward K. BrownJr.Jr. & Steven N. Sterious. (2007) In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay. Psychopharmacology 193:2, pages 187-197.
Crossref
Crossref
Renata A. Da Silva, Aderley S.S. Da Silva, Marine Josiane Poffo, Déborah C. Ribas, Moacir Serralvo Faria, José Marino-Neto & Marta A. Paschoalini. (2007) Feeding behavior after metergoline or GR-46611 injections into the paraventricular nucleus of the hypothalamus in the pigeon. Behavioural Brain Research 179:2, pages 248-257.
Crossref
Crossref
Oliver Stiedl, Ilga Misane, Melanie Koch, Tommy Pattij, Michael Meyer & Sven Ove Ögren. (2007) Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice. Neuropharmacology 52:3, pages 949-957.
Crossref
Crossref
K. Stachowicz, E. Chojnacka-Wójcik, K. Kłak & A. Pilc. (2007) Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacology 52:2, pages 306-312.
Crossref
Crossref
J. McDaid, C.E. Tedford, A.R. Mackie, J.E. Dallimore, A.L. Mickiewicz, F. Shen, J.M. Angle & T.C. Napier. (2007) Nullifying drug-induced sensitization: Behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats. Drug and Alcohol Dependence 86:1, pages 55-66.
Crossref
Crossref
Jean-Philippe Guilloux, Denis J P David, Bruno P Guiard, Franck Chenu, Christelle Repérant, Miklos Toth, Michel Bourin & Alain M Gardier. (2006) Blockade of 5-HT1A Receptors by (±)-Pindolol Potentiates Cortical 5-HT Outflow, but not Antidepressant-Like Activity of Paroxetine: Microdialysis and Behavioral Approaches in 5-HT1A Receptor Knockout Mice. Neuropsychopharmacology 31:10, pages 2162-2172.
Crossref
Crossref
David Centurión, Suneet Mehotra, Araceli Sánchez-López, Saurabh Gupta, Antoinette MaassenVanDenBrink & Carlos M. Villalón. (2006) Potential vascular α1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. European Journal of Pharmacology 535:1-3, pages 234-242.
Crossref
Crossref
Pierre Clément, Jacques Bernabé, Hosein Kami Kia, Laurent Alexandre & François Giuliano. (2006)
D2-Like Receptors Mediate the Expulsion Phase of Ejaculation Elicited by 8-Hydroxy-2-(di-
N
-propylamino)tetralin in Rats
. Journal of Pharmacology and Experimental Therapeutics 316:2, pages 830-834.
Crossref
Crossref
Karim Asgari, Stephanie Body, Victoria K. Bak, Zhong-qi Zhang, Jonathan F. Rickard, Jeffrey C. Glennon, Kevin C.F. Fone, Christopher M. Bradshaw & Elem??r Szabadi. (2006) Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats. Behavioural Pharmacology 17:1, pages 51-59.
Crossref
Crossref
Mark John Millan. (2005) Serotonin 5-HT2C Receptors as a Target for the Treatment of Depressive and Anxious States: Focus on Novel Therapeutic Strategies. Therapies 60:5, pages 441-460.
Crossref
Crossref
S. Body, K. Asgari, J. F. Rickard, Z. Zhang, K. C. F. Fone, C. M. Bradshaw & E. Szabadi. (2005) Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour. Psychopharmacology 181:2, pages 289-298.
Crossref
Crossref
Michel Bourin & Brid Aine Nic Dhonnchadha. (2005) 5-HT2 receptors and anxiety. Drug Development Research 65:3, pages 133-140.
Crossref
Crossref
Mark P. Wentland, Xufeng Sun, Yigong Bu, Rongliang Lou, Dana J. Cohen & Jean M. Bidlack. (2005) Redefining the structure–activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocine. Bioorganic & Medicinal Chemistry Letters 15:10, pages 2547-2551.
Crossref
Crossref
Valiya Veettil Mohanan, Finla Chathu & Cheramadathikudyil S. Paulose. (2005) Decreased 5-HT2C receptor binding in the cerebral cortex and brain stem during pancreatic regeneration in rats. Molecular and Cellular Biochemistry 272:1-2, pages 165-170.
Crossref
Crossref
Michael H Baumann, Robert D Clark, Allison G Budzynski, John S Partilla, Bruce E Blough & Richard B Rothman. (2004) N-Substituted Piperazines Abused by Humans Mimic the Molecular Mechanism of 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’). Neuropsychopharmacology 30:3, pages 550-560.
Crossref
Crossref
K. Asgari, S. Body, J. F. Rickard, Z. Zhang, K. C. F. Fone, C. M. Bradshaw & E. Szabadi. (2005) Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors. Behavioural Pharmacology 16:1, pages 43-51.
Crossref
Crossref
Alfredo Meneses. (2004) Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behavioural Brain Research 155:2, pages 275-282.
Crossref
Crossref
Sunila G. Nair & Gary A. Gudelsky. (2004)
Activation of 5‐HT
2
receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat
. Synapse 53:4, pages 202-207.
Crossref
Crossref
G.L. Dalton, M.D. Lee, G.A. Kennett, C.T. Dourish & P.G. Clifton. (2004) mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology 46:5, pages 663-671.
Crossref
Crossref
Hideaki Obata, Shigeru Saito, Shinobu Sakurazawa, Masayuki Sasaki, Tadashi Usui & Fumio Goto. (2004) Antiallodynic effects of intrathecally administered 5-HT2C receptor agonists in rats with nerve injury. Pain 108:1, pages 163-169.
Crossref
Crossref
David E Nichols. (2004) Hallucinogens. Pharmacology & Therapeutics 101:2, pages 131-181.
Crossref
Crossref
Chi-Li Gong, Yung-Tsung Chiu, Nai-Nu Lin, Shinn-Zong Lin, Fu-Chou Cheng & Jon-Son Kuo. (2004) Inhibitory actions of serotonin on glutamate release in dorsal medulla suppress systemic arterial pressure of cats. Neuroscience Letters 355:1-2, pages 73-76.
Crossref
Crossref
Araceli Sánchez-López, David Centurión, Erika Vázquez, Udayasankar Arulmani, Pramod R Saxena & Carlos M Villalón. (2003)
Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT
1
and putative 5-ht
5A/5B
receptors
. British Journal of Pharmacology 140:4, pages 725-735.
Crossref
Crossref
Laurence H. Tecott & Luna Abdallah. (2014)
Mouse Genetic Approaches to Feeding Regulation: Serotonin 5-HT
2C
Receptor Mutant Mice
. CNS Spectrums 8:8, pages 578-588.
Crossref
Crossref
Janaina M Zanoveli, Regina L Nogueira & Hélio ZangrossiJr.Jr.. (2003) Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. European Journal of Pharmacology 473:2-3, pages 153-161.
Crossref
Crossref
Tiina Koskinen, Antti Haapalinna & Jouni Sirvi. (2003)
α-Adrenoceptor-Mediated Modulation of 5-HT
2
Receptor Agonist Induced Impulsive Responding in a 5-Choice Serial Reaction Time Task
. Pharmacology & Toxicology 92:5, pages 214-225.
Crossref
Crossref
H. Kojima, T. Terao, M. Iwakawa, A. Soya, N. Inoue, Y. Shiraishi, Y. Son, S. Soeda, N. Ueda, R. Yoshimura & J. Nakamura. (2003) Paroxetine as a 5-HT neuroendocrine probe. Psychopharmacology 167:1, pages 97-102.
Crossref
Crossref
Marc Potenza. 2003. Handbook of Medical Psychiatry. Handbook of Medical Psychiatry
683
699
.
H. Jørgensen, M. Riis, U. Knigge, A. Kjaer & J. Warberg. (2003) Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion. Journal of Neuroendocrinology 15:3, pages 242-249.
Crossref
Crossref
Jana Sawynok & Allison Reid. (2003) Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats. Pain 102:1, pages 179-186.
Crossref
Crossref
Neera Ghaziuddin, Kathy Welch & John Greden. (2003) Central Serotonergic Effects of m-Chlorophenylpiperazine (mCPP) among Normal Control Adolescents. Neuropsychopharmacology 28:1, pages 133-139.
Crossref
Crossref
Andrew C. McCreary, Malgorzata Filip & Kathryn A. Cunningham. (2003) Discriminative stimulus properties of (±)-fenfluramine: The role of 5-HT₂ receptor subtypes.. Behavioral Neuroscience 117:2, pages 212-221.
Crossref
Crossref
F Miranda, E Hong, H Sánchez & D.N Velázquez-Martı́nez. (2003) Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT1A/1B/2C receptors. Pharmacology Biochemistry and Behavior 74:2, pages 371-380.
Crossref
Crossref
N.R Sullivan Hanley & L.D Van de Kar. 2003.
189
255
.
Tineke Klaassen, Wim J Riedel, Herman M van Praag, Paul P.C.A Menheere & Eric Griez. (2002) Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Research 113:1-2, pages 29-40.
Crossref
Crossref
H. Jørgensen, U. Knigge, A. Kjær, M. Møller & J. Warberg. (2002) Serotonergic Stimulation of Corticotropin‐Releasing Hormone and Pro‐Opiomelanocortin Gene Expression. Journal of Neuroendocrinology 14:10, pages 788-795.
Crossref
Crossref
Y-L Liu, DJ Heal & MJ Stock. (2002) Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine. International Journal of Obesity 26:9, pages 1245-1253.
Crossref
Crossref
I. M. Anderson, L. Clark, R. Elliott, B. Kulkarni, S. R. Williams & J. F. W. Deakin. (2002) 5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13:12, pages 1547-1551.
Crossref
Crossref
Begoña Fernández-Pastor & J.Javier Meana. (2002) In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic α2-adrenoceptors. European Journal of Pharmacology 442:3, pages 225-229.
Crossref
Crossref
Paul J. Currie, Christina D. Coiro, Tippy Niyomchai, Alena Lira & Farnoosh Farahmand. (2002) Hypothalamic paraventricular 5-hydroxytryptamine: Receptor-specific inhibition of NPY-stimulated eating and energy metabolism. Pharmacology Biochemistry and Behavior 71:4, pages 709-716.
Crossref
Crossref
Zdzisław Chilmonczyk, Marcin Cybulski, Joanna Iskra-Jopa, Ewa Chojnacka-Wójcik, Ewa Tatarczyńska, Aleksandra Kłodzińska, Andrzej Leś, Agnieszka Bronowska & Ingebrigt Sylte. (2002) Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors. Il Farmaco 57:4, pages 285-301.
Crossref
Crossref
José A. Terrón. (2002) Is the 5-HT7 receptor involved in the pathogenesis and prophylactic treatment of migraine?. European Journal of Pharmacology 439:1-3, pages 1-11.
Crossref
Crossref
Susan K. Hemrick-Luecke & David C. Evans. (2002) Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT2A receptor mediation of the HPA axis. Neuropharmacology 42:2, pages 162-169.
Crossref
Crossref
S.D. Gleason, V.L. Lucaites, H.E. Shannon, D.L. Nelson & J.D. Leander. (2001) m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors. Behavioural Pharmacology 12:8, pages 613-620.
Crossref
Crossref
Floortje E. Scheepers, Christine C. Gispen de Wied & René S. Kahn. (2001) The Effect of Olanzapine Treatment on m-Chlorophenylpiperazine-Induced Hormone Release in Schizophrenia. Journal of Clinical Psychopharmacology 21:6, pages 575-582.
Crossref
Crossref
Alfredo Meneses & José A. Terrón. (2001) Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation. Behavioural Brain Research 121:1-2, pages 21-28.
Crossref
Crossref
Laurent Bardin, Jean-Pierre Tarayre, Wouter Koek & Francis C Colpaert. (2001) In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. European Journal of Pharmacology 421:2, pages 109-114.
Crossref
Crossref
Francesc Artigas, Pau Celada, Marc Laruelle & Albert Adell. (2001) How does pindolol improve antidepressant action?. Trends in Pharmacological Sciences 22:5, pages 224-228.
Crossref
Crossref
Julie K Staley, Christopher H Van Dyck, Ping-Zhong Tan, Mohammed Al Tikriti, Quinn Ramsby, Heide Klump, Chin Ng, Pradeep Garg, Robert Soufer, Ronald M Baldwin & Robert B Innis. (2001) Comparison of [18F]altanserin and [18F]deuteroaltanserin for PET imaging of serotonin2A receptors in baboon brain: pharmacological studies. Nuclear Medicine and Biology 28:3, pages 271-279.
Crossref
Crossref
Gal Meiri, Itzhak Z. Ben‐Zion, Benjamin D. Greenberg, Dennis L. Murphy & Jonathan Benjamin. (2001) Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers. Human Psychopharmacology: Clinical and Experimental 16:3, pages 237-245.
Crossref
Crossref
David Centurión, Araceli Sánchez‐López, Peter De Vries, Pramod R Saxena & Carlos M Villalón. (2009)
The GR127935‐sensitive 5‐HT
1
receptors mediating canine internal carotid vasoconstriction: resemblance to the 5‐HT
1B
, but not to the 5‐HT
1D
or 5‐ht
1F
, receptor subtype
. British Journal of Pharmacology 132:5, pages 991-998.
Crossref
Crossref
G Di Giovanni, V Di Matteo, V La Grutta & E Esposito. (2001) m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:1, pages 111-116.
Crossref
Crossref
H. S?nchez & D. N. Vel?zquez-Mart?nez. (2016) Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Journal of Psychopharmacology 15:1, pages 29-36.
Crossref
Crossref
Aygul Balcioglu & Richard J Wurtman. (2000) Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid. Neuropharmacology 39:12, pages 2352-2359.
Crossref
Crossref
Katsuya Suemaru, Hiroaki Araki & Yutaka Gomita. (2000) Involvement of 5-hydroxytryptamine1A receptors in nicotine-induced tail tremor in rats. European Journal of Pharmacology 408:1, pages 19-23.
Crossref
Crossref
Hemmie H.G Berendsen. (2000) The role of serotonin in hot flushes. Maturitas 36:3, pages 155-164.
Crossref
Crossref
Martine Hascoët, Michel Bourin & Brid A Nic Dhonnchadha. (2000) The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test. Pharmacology Biochemistry and Behavior 67:1, pages 45-53.
Crossref
Crossref
M.C. Wolff & J.D. Leander. (2000) A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon. Behavioural Pharmacology 11:5, pages 355-364.
Crossref
Crossref
Anissa Abi-Dargham & John Krystal. 2000. Neurotransmitter Receptors in Actions of Antipsychotic Medications. Neurotransmitter Receptors in Actions of Antipsychotic Medications
79
107
.
C. Sánchez & J. Arnt. (2000) In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics. Behavioural Pharmacology 11:3 & 4, pages 291-298.
Crossref
Crossref
Sharon C. Cheetham & David J. Heal. 2000. Biological Psychiatry. Biological Psychiatry
511
567
.
Chiara M Portas, Bjørn Bjorvatn & Reidun Ursin. (2000) Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Progress in Neurobiology 60:1, pages 13-35.
Crossref
Crossref
D. E. Nichols. 2000. Serotoninergic Neurons and 5-HT Receptors in the CNS. Serotoninergic Neurons and 5-HT Receptors in the CNS
563
585
.
L. D. Van De Kar. 2000. Serotoninergic Neurons and 5-HT Receptors in the CNS. Serotoninergic Neurons and 5-HT Receptors in the CNS
537
562
.
G. K. Aghajanian & R. Andrade. 2000. Serotoninergic Neurons and 5-HT Receptors in the CNS. Serotoninergic Neurons and 5-HT Receptors in the CNS
499
535
.
Giuseppe Di Giovanni, Vincenzo Di Matteo, Michele Di Mascio & Ennio Esposito. (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:1, pages 53-61.
Crossref
Crossref
Hongmei Yan & Tommy Lewander. (1999) Differential tissue distribution of the enantiomers of racemic pindolol in the rat. European Neuropsychopharmacology 10:1, pages 59-62.
Crossref
Crossref
Marta Pazzagli, Maria Grazia Giovannini & Giancarlo Pepeu. (1999) Trazodone increases extracellular serotonin levels in the frontal cortex of rats. European Journal of Pharmacology 383:3, pages 249-257.
Crossref
Crossref
B. Olivier, J. Gommans, J. Van Der Gugten, J.A. Bouwknecht, A.H.J. Herremans, T. Patty & T.H. Hijzen. (1999) Stimulus Properties of the Selective 5-HT Reuptake Inhibitor Fluvoxamine in Conditioned Taste Aversion Procedures. Pharmacology Biochemistry and Behavior 64:2, pages 213-220.
Crossref
Crossref
Panagiota Galanopoulou & George Giannakopoulos. (2006) Mesulergine: A Review. CNS Drug Reviews 5:3, pages 233-248.
Crossref
Crossref
Lakshmi N. Yatham, Don Lint, Raymond W. Lam & Athanasios P. Zis. (1999) Adverse Effects of Pindolol Augmentation in Patients With Bipolar Depression. Journal of Clinical Psychopharmacology 19:4, pages 383-384.
Crossref
Crossref
G Grignaschi, E Fanelli, I Scagnol & R Samanin. (2009) Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats. British Journal of Pharmacology 127:5, pages 1190-1194.
Crossref
Crossref
Hemmie H.G. Berendsen & Chris L.E. Broekkamp. (1999) Antagonism of the 5-HT1A receptor stimulus in a conditioned taste aversion procedure. European Neuropsychopharmacology 9:4, pages 345-349.
Crossref
Crossref
Jon-Son Kuo, Hsing-Tan Li, Nai-Nu Lin, Chung-Shi Yang & Fu-Chou Cheng. (1999) Dorsal facial area of cat medulla; 5-HT2 action on glutamate release in regulating common carotid blood flow. Neuroscience Letters 266:2, pages 137-140.
Crossref
Crossref
Jørgensen, Knigge, Kjaer & Warberg. (2002) Adrenocorticotropic Hormone Secretion in Rats Induced by Stimulation with Serotonergic Compounds. Journal of Neuroendocrinology 11:4, pages 283-290.
Crossref
Crossref
John P. Redrobe & Michel Bourin. (2014) Augmentation of Antidepressant Pharmacotherapy: A Preclinical Approach Using the Mouse Forced Swimming Test. CNS Spectrums 4:4, pages 73-82.
Crossref
Crossref
Paul J Schwartz, Erick H Turner, Diego Garcia-Borreguero, Jan Sedway, Rina G Vetticad, Thomas A Wehr, Dennis L Murphy & Norman E Rosenthal. (1999) Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT1A receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects. Psychiatry Research 86:1, pages 9-28.
Crossref
Crossref
E. Toscano, G. Romero, C. Oset & J. Del Rı́o. (1999) Pharmacological characteristics and regulation of 5-HT receptor-stimulated phosphoinositide hydrolysis in the rat spinal cord. General Pharmacology: The Vascular System 32:3, pages 351-358.
Crossref
Crossref
Shin Yamazaki, Vinessa Alones, Wendy Irelan & Michael Menaker. (1999) Serotonin-containing cell bodies in novel brain LOCATIONS. NeuroReport 10:2, pages 431-435.
Crossref
Crossref
Carlos M Villalón, Peter De Vries, Gonzalo Rabelo, David Centurión, Araceli Sánchez‐López & Pramod Saxena. (2009)
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT
1B/1D
receptors and
α
2
‐adrenoceptors
. British Journal of Pharmacology 126:3, pages 585-594.
Crossref
Crossref
Leslie Matuszewich, Daniel S Lorrain, Robert Trujillo, Juan Dominguez, Susan K Putnam & Elaine M Hull. (1999) Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist. Brain Research 820:1-2, pages 55-62.
Crossref
Crossref
M. Franklin, R. D. Craven, B. Dowling, G. Campling, J. M. Elliott & P. J. Cowen. (2016) Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat. Journal of Psychopharmacology 13:1, pages 58-63.
Crossref
Crossref
Joyce H. Hurley, Laura J. Bloem, Fred Pavalko, Jian Liu, Mingting Tian, Jay R. Simon & Lei Yu. (1999) Structure-Function Studies of the Eighth Hydrophobic Domain of a Serotonin Receptor. Journal of Neurochemistry 72:1, pages 413-421.
Crossref
Crossref
Jeffrey A Lieberman, Richard B Mailman, Gary Duncan, Lin Sikich, Miranda Chakos, David E Nichols & John E Kraus. (1998) Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry 44:11, pages 1099-1117.
Crossref
Crossref
Henrik Jørgensen, Ulrich Knigge, Andreas Kjær, Thomas Vadsholt & Jørgen Warberg. (1998) Serotonergic involvement in stress-induced ACTH release. Brain Research 811:1-2, pages 10-20.
Crossref
Crossref
G Grignaschi, R W Invernizzi, E Fanelli, C Fracasso, S Caccia & R Samanin. (2009)
Citalopram‐induced hypophagia is enhanced by blockade of 5‐HT
1A
receptors: role of 5‐HT
2C
receptors
. British Journal of Pharmacology 124:8, pages 1781-1787.
Crossref
Crossref
Paul J. Currie & Donald V. Coscina. (1998) 5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient1Published on the world wide web on 10 July 1998.1. Brain Research 803:1-2, pages 212-217.
Crossref
Crossref
John P. Redrobe, Michel Bourin, Marie Claude Colombel & Glen B. Baker. (2016) Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. Journal of Psychopharmacology 12:4, pages 348-355.
Crossref
Crossref
Carlos M. Villalón, David Centurión, Gonzalo Rabelo, Peter de Vries, Pramod R. Saxena & Araceli Sánchez‐López. (2009)
The 5‐HT
1
‐like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5‐HT
1A
, 5‐HT
1B
and 5‐HT
1D
subtypes
. British Journal of Pharmacology 124:5, pages 1001-1011.
Crossref
Crossref
Mary Jane Espey, Huan-Ji Du & John William Downie. (1998) Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats. Brain Research 798:1-2, pages 101-108.
Crossref
Crossref
Concetta M. DeCaria, Tomer Begaz & Eric Hollander. (2014) Serotonergic and Noradrenergic Function in Pathological Gambling. CNS Spectrums 3:6, pages 38-47.
Crossref
Crossref
Gerard J. Marek & George K. Aghajanian. (1998) Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action. Drug and Alcohol Dependence 51:1-2, pages 189-198.
Crossref
Crossref
Stefan Berg, Lars-Gunnar Larsson, Lucy Rényi, Svante B. Ross, Seth-Olof Thorberg & Gun Thorell-Svantesson. (1998)
(
R
)-(+)-2-[[[3-(Morpholinomethyl)-2
H
-chromen-8-yl]oxy]methyl]morpholine Methanesulfonate: A New Selective Rat 5-Hydroxytryptamine
1B
Receptor Antagonist
. Journal of Medicinal Chemistry 41:11, pages 1934-1942.
Crossref
Crossref
Scott Helsley, David Fiorella, Richard A. Rabin & J.C. Winter. (1998) A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 22:4, pages 649-663.
Crossref
Crossref
Kevin C. F. Fone, Rachel H. Austin, Ian A. Topham, Guy A. Kennett & Taniya Punhani. (2009)
Effect of chronic
m
‐CPP on locomotion, hypophagia, plasma corticosterone and 5‐HT
2C
receptor levels in the rat
. British Journal of Pharmacology 123:8, pages 1707-1715.
Crossref
Crossref
Vincenzo Di Matteo, Giuseppe Di Giovanni, Michele Di Mascio & Ennio Esposito. (1998) Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37:2, pages 265-272.
Crossref
Crossref
Hans O Kalkman, Vroni Neumann, Joachim Nozulak & Mark D Tricklebank. (1998) Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat. European Journal of Pharmacology 343:2-3, pages 201-207.
Crossref
Crossref
Scott D Gleason & Harlan E Shannon. (1998) Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice. European Journal of Pharmacology 341:2-3, pages 135-138.
Crossref
Crossref
Julio Cortijo, Miguel Martí‐Cabrera, Eva Bernabeu, Teresa Domènech, Josep Bou, Andrés G. Fernández, Jorge Beleta, José M. Palacios & Esteban J. Morcillo. (2009) Characterization of 5‐HT receptors on human pulmonary artery and vein: functional and binding studies. British Journal of Pharmacology 122:7, pages 1455-1463.
Crossref
Crossref
Paula O Mora, Cristina Ferreira Netto & Frederico G Graeff. (1997) Role of 5-HT2A and 5-HT2C Receptor Subtypes in the Two Types of Fear Generated by the Elevated T-Maze. Pharmacology Biochemistry and Behavior 58:4, pages 1051-1057.
Crossref
Crossref
Maria Zhelyazkova-Savova, Maria Grazia Giovannini & Giancarlo Pepeu. (1997) Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: an in vivo microdialysis study. Neuroscience Letters 236:3, pages 151-154.
Crossref
Crossref
Anita Sharma, Taniya Punhani & Kevin C.F. Fone. (1997) Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: Effect of 5,7-dihydroxytryptamine. Synapse 27:1, pages 45-56.
Crossref
Crossref
Daniela Crespi, Tiziana Mennini & Marco Gobbi. (1997)
Carrier-dependent and Ca
2+
-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxy-methamphetamine,
p
-chloroamphetamine and (+)-fenfluramine
. British Journal of Pharmacology 121:8, pages 1735-1743.
Crossref
Crossref
Helen C. Jackson, M. Clair Bearham, Lisa J. Hutchins, Sarah E. Mazurkiewicz, Andrew M. Needham & David J. Heal. (1997) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. British Journal of Pharmacology 121:8, pages 1613-1618.
Crossref
Crossref
S. J. MacLennan, L. A. Luong, J. R. Jasper, Z. P. To & R. M. Eglen. (1997)
Characterization of
α
2
-adrenoceptors mediating contraction of dog saphenous vein: identity with the human
α
2A
subtype
. British Journal of Pharmacology 121:8, pages 1721-1729.
Crossref
Crossref
B. Söderpalm, G. Andersson, C. Enerbäck & J.A. Engel. (1997) In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with brain GABAA/ benzodiazepine receptor complexes. Neuropharmacology 36:8, pages 1071-1077.
Crossref
Crossref
Carlos M Villalón, Jan P C Heiligers, David Centurión, Peter De Vries & Pramod R Saxena. (2009)
Characterization of putative 5‐HT
7
receptors mediating tachycardia in the cat
. British Journal of Pharmacology 121:6, pages 1187-1195.
Crossref
Crossref
Jean-Pierre Lindenmayer, Adityanjee, Marc Vital-Herne, Nigel Bark, Sandra Grochowski & Nancy Moynihan. (1997) Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients. Biological Psychiatry 42:1, pages 6-12.
Crossref
Crossref
STEVEN M. SOUTHWICK, C. A. MORGAN, A. DOUGLAS BREMNER, CHRISTIAN G. GRILLON, JOHN H. KRYSTAL, LINDA M. NAGY & DENNIS S. CHARNEY. (1997) Noradrenergic Alterations in Posttraumatic Stress Disorder. Annals of the New York Academy of Sciences 821:1 Psychobiology, pages 125-141.
Crossref
Crossref
HE Connor, W Feniuk, DT Beattie, PC North, AW Oxford, DA Saynor & PPA Humphrey. (2016) Naratriptan. Cephalalgia 17:3, pages 145-152.
Crossref
Crossref
José A. Terrón. (2009)
Role of 5‐ht
7
receptors in the long‐lasting hypotensive response induced by 5‐hydroxytryptamine in the rat
. British Journal of Pharmacology 121:3, pages 563-571.
Crossref
Crossref
Jan Gommans, Theo H. Hijzen, Robert A. Maes & Berend Olivier. (1997) Discriminative stimulus properties of eltoprazine. Life Sciences 61:1, pages 11-19.
Crossref
Crossref
Shui-Wang Ying & Benjamin Rusak. (1997) 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Research 755:2, pages 246-254.
Crossref
Crossref
Daniel Hommer, Paul Andreasen, Daniel Rio, Wendol Williams, Urs Ruttimann, Reza Momenan, Alan Zametkin, Robert Rawlings & Markku Linnoila. (1997)
Effects of
m
-Chlorophenylpiperazine on Regional Brain Glucose Utilization: A Positron Emission Tomographic Comparison of Alcoholic and Control Subjects
. The Journal of Neuroscience 17:8, pages 2796-2806.
Crossref
Crossref
L. Buydens‐Branchey, M. Branchey, P. Fergeson, J. Hudson & C. McKernin. (2006)
Hormonal, Psychological, and Alcohol Craving Changes after
m
‐Chlorophenylpiperazine Administration in Alcoholics
. Alcoholism: Clinical and Experimental Research 21:2, pages 220-227.
Crossref
Crossref
E. Clea Warburton, Amanda A. Harrison, Trevor W. Robbins & Barry J. Everitt. (1997) Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behavioural Brain Research 84:1-2, pages 247-258.
Crossref
Crossref
P.M CALLAHAN & K.A CUNNINGHAM. (1997) Modulation of the Discriminative Stimulus Properties of Cocaine: Comparison of the Effects of Fluoxetine with 5-HT1A and 5-HT1B Receptor Agonists. Neuropharmacology 36:3, pages 373-381.
Crossref
Crossref
Nicolaas H. Prins, Michel R. Briejer & Jan A.J. Schuurkes. (1997) Characterization of the contraction to 5-HT in the canine colon longitudinal muscle. British Journal of Pharmacology 120:4, pages 714-720.
Crossref
Crossref
Scott Shapiro. (1997) Neurotransmission by Neurons That Use Serotonin, Noradrenaline, Glutamate, Glycine, and γ-Aminobutyric Acid in the Normal and Injured Spinal Cord. Neurosurgery 40:1, pages 168-177.
Crossref
Crossref
Laure Buydens‐Branchey, Marc Branchey, Paul Fergeson, Jeffrey Hudson & Craig McKernin. (2010) Craving for Cocaine in Addicted Users. The American Journal on Addictions 6:1, pages 65-73.
Crossref
Crossref
Scott Shapiro. (1997) Neurotransmission by Neurons That Use Serotonin, Noradrenaline, Glutamate, Glycine, and ??-Aminobutyric Acid in the Normal and Injured Spinal Cord. Neurosurgery 40:1, pages 168-177.
Crossref
Crossref
Gunnar Andersson, Agneta Albinsson, Anders Björk & Jan Svartengren. (2006)
FG5893: A Potential New Generation Anxiolytic/Antidepressant Drug with High Affinity for 5‐HT
1A
and 5‐HT
2A
Receptors
. CNS Drug Reviews 2:4, pages 363-383.
Crossref
Crossref
W. M. A. Verhoeven & S. Tuinier. (1996) The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study. Journal of Intellectual Disability Research 40:6, pages 502-508.
Crossref
Crossref
John P. Redrobe, Cliona P. MacSweeney & Michel Bourin. (1996) The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. European Journal of Pharmacology 318:2-3, pages 213-220.
Crossref
Crossref
Jerònia Lladó, Susana Esteban & Jesús A. García-Sevilla. (1996) The α2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo. Neuroscience Letters 218:2, pages 111-114.
Crossref
Crossref
Michael Maes & Herbert Y. Meltzer. (1996) Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers. Psychiatry Research 64:3, pages 147-159.
Crossref
Crossref
Adityanjee, A K Pandurangi, J P Lindenmayer & V Chowdary Jampala. (1996) m-CPP Challenge Test as Predictor of Response to Clozapine in Schizophrenia. Psychiatric Annals 26:7, pages 395-399.
Crossref
Crossref
Pascale Mazzola-Pomietto, Charanjit S. Aulakh & Dennis L. Murphy. (1996) NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats. European Journal of Pharmacology 308:3, pages 329-333.
Crossref
Crossref
Hemmie H.G. Berendsen, Robert C.H. Kester, Bernard W.M.M. Peeters & Chris L.E. Broekkamp. (1996) Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone. European Journal of Pharmacology 308:2, pages 103-111.
Crossref
Crossref
E. F. Coccaro, R. J. Kavoussi, M. Oakes, T. B. Cooper & R. Hauger. (1996) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response tod-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126:1, pages 24-30.
Crossref
Crossref
Yumi Sugimoto, Jun Yamada, Tomoko Yoshikawa & Kazuyoshi Horisaka. (1996) Effects of the receptor agonist 1-(3-chlorophenyl)piperazine on plasma glucose levels of rats. European Journal of Pharmacology 307:1, pages 75-80.
Crossref
Crossref
N. K. Popova, E. M. Nikulina, S. N. Shigantsov, I. F. Plyusnina & T. G. Amstislavskaya. (1996) Effect of antagonists and agonists of 5-HT1 and 5-HT2 serotonin receptors on the predator aggressiveness of wild norway rats. Bulletin of Experimental Biology and Medicine 121:6, pages 621-623.
Crossref
Crossref
R. Invernizzi, M. Bramante & R. Samanin. (1996) Role of 5-HT1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacology Biochemistry and Behavior 54:1, pages 143-147.
Crossref
Crossref
Stephan Hjorth. (1996) (−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European Journal of Pharmacology 303:3, pages 183-186.
Crossref
Crossref
S. P. Vickers, P. G. Clifton & C. T. Dourish. (1996) Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype. Psychopharmacology 125:2, pages 168-175.
Crossref
Crossref
Susana Esteban, Jerónia Lladó & Jesús A. García-Sevilla. (1996) α2-autoreceptors and α2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the α2-adrenoceptor subtypes. Naunyn-Schmiedeberg's Archives of Pharmacology 353:4, pages 391-399.
Crossref
Crossref
Lawrence M. Katz, Lawren Nathan, Cynthia M. Kuhn & Saul M. Schanberg. (1996) Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C Receptors. Psychoneuroendocrinology 21:2, pages 219-235.
Crossref
Crossref
Erla R. Smith, Sonia R. Kacker, Alexander Raskin, Paul T. Yun, Julian M. Davidson, Brian B. Hoffman & John T. Clark. (1996) Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats. Physiology & Behavior 59:2, pages 241-246.
Crossref
Crossref
Barry W. Siegel, Jules Freedman, Mark J. Vaal & Bruce M. Baron. (1996) Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors. European Journal of Pharmacology 296:3, pages 307-318.
Crossref
Crossref
Giuliano Grignaschi, Francesca Sironi & Rosario Samanin. (1996) Stimulation of 5-HT 2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor. Brain Research 708:1-2, pages 173-176.
Crossref
Crossref
P. Mazzola-Pomietto, C. S. Aulakh, K. M. Wozniak & D. L. Murphy. (1996) Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology 123:4, pages 333-339.
Crossref
Crossref
T.A. Lutz, E. Del Prete, B. Walzer & E. Scharrer. (1996) The histaminergic, but not the serotoninergic, system mediates amylin's anorectic effect. Peptides 17:8, pages 1317-1322.
Crossref
Crossref
F. F. Matos, C. Urban & F. D. Yocca. (1996) Serotonin (5-HT) release in the dorsal raph� and ventral hippocampus: Raph� control of somatodendritic and terminal 5-HT release. Journal of Neural Transmission 103:1-2, pages 173-190.
Crossref
Crossref
J. Maj, Z. Rogóż, G. Skuza & K. Wędzony. (1996) The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Journal of Neural Transmission 103:1-2, pages 131-146.
Crossref
Crossref
John M. Dickenson & Stephen J. Hill. (2012)
Coupling of an endogenous 5‐HT
1B
‐like receptor to increases in intracellular calcium through a pertussis toxin‐sensitive mechanism in CHO‐K1 cells
. British Journal of Pharmacology 116:7, pages 2889-2896.
Crossref
Crossref
Nobuaki Takeshita & Isamu Yamaguchi. (1995) Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice. British Journal of Pharmacology 116:8, pages 3133-3138.
Crossref
Crossref
Subhash C. Pandey & Ghanshyam N. Pandey. (1995) Modulation of serotonin2A/2C receptors and these receptor-linked phosphoinositide system by ethanol. Behavioural Brain Research 73:1-2, pages 235-238.
Crossref
Crossref
Louis D. Van de Kar, Peter A. Rittenhouse, Qian Li & Andrew D. Levy. (1995) Serotonergic regulation of renin and prolactin secretion. Behavioural Brain Research 73:1-2, pages 203-208.
Crossref
Crossref
Jana Sawynok & Allison Reid. (1995) Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behavioural Brain Research 73:1-2, pages 63-68.
Crossref
Crossref
Luigi Cervo & Rosario Samanin. (1995) 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats. Pharmacology Biochemistry and Behavior 52:4, pages 671-676.
Crossref
Crossref
J.M. Monti, D. Monti, H. Jantos & A. Ponzoni. (1995) Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat. Neuropharmacology 34:12, pages 1647-1651.
Crossref
Crossref
D. Fiorella, S. Helsley, R. A. Rabin & J. C. Winter. (1995) 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects ofm-chlorophenylpiperazine. Psychopharmacology 122:3, pages 237-243.
Crossref
Crossref
Robert M. Zacharko, Diana Koszycki, Paul D. Mendella & Jacques Bradwejn. (1995) Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization. Progress in Neurobiology 47:4-5, pages 371-423.
Crossref
Crossref
M. Riekkinen, J. Sirviö, T. Toivanen & P. RiekkinenJrJr. (1995) Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior. Psychopharmacology 122:2, pages 137-146.
Crossref
Crossref
Silvio Garattini. (2012) Biological Actions of Drugs Affecting Serotonin and Eating. Obesity Research 3:S4.
Crossref
Crossref
Jaime M. Monti, Héctor Jantos, Rodolfo Silveira, Miguel Reyes-Parada & Cecilia Scorza. (1995) Sleep and waking in 5,7-DHT-lesioned or (−)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone. Pharmacology Biochemistry and Behavior 52:2, pages 305-312.
Crossref
Crossref
David Fiorella, R. A. Rabin & J. C. Winter. (1995) Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives. Psychopharmacology 121:3, pages 357-363.
Crossref
Crossref
D. Fiorella, R. A. Rabin & J. C. Winter. (1995) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis. Psychopharmacology 121:3, pages 347-356.
Crossref
Crossref
A. S�derpalm, O. Blomqvist & B. S�derpalm. (1995) The yohimbine-induced anticonflict effect in the rat, part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms. Journal of Neural Transmission 100:3, pages 175-189.
Crossref
Crossref
Simona Prisco & Ennio Esposito. (2012) Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. British Journal of Pharmacology 116:2, pages 1923-1931.
Crossref
Crossref
Displaying 200 of 497 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list